PDT Partners’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.4M | Buy |
145,379
+7,884
| +6% | +$401K | 0.42% | 48 |
|
|
2025
Q1 | $6.19M | Buy |
137,495
+23,782
| +21% | +$1.07M | 0.44% | 37 |
|
|
2024
Q4 | $4.7M | Buy |
113,713
+1
| +0% | +$41 | 0.42% | 40 |
|
|
2024
Q3 | $4.43M | Buy |
113,712
+74,349
| +189% | +$2.9M | 0.39% | 39 |
|
|
2024
Q2 | $1.35M | Buy |
+39,363
| New | +$1.35M | 0.13% | 284 |
|
|
2022
Q3 | – | Sell |
-16,607
| Closed | -$323K | – | 985 |
|
|
2022
Q2 | $323K | Sell |
16,607
-124
| -0.7% | -$2.41K | 0.03% | 725 |
|
|
2022
Q1 | $368K | Sell |
16,731
-5,019
| -23% | -$110K | 0.03% | 655 |
|
|
2021
Q4 | $347K | Buy |
+21,750
| New | +$347K | 0.03% | 633 |
|
|
2021
Q3 | – | Sell |
-18,546
| Closed | -$321K | – | 854 |
|
|
2021
Q2 | $321K | Buy |
+18,546
| New | +$321K | 0.02% | 605 |
|